ArticleBioinformatics (Oxford, England)2026
StrucPTM: a database of structurally validated protein modifications and their conformational variation.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationPost-translational modifications (PTMs) alter functional states and interaction specificity largely through the conformational changes they impose on protein structure. However, most existing resources remain sequence-centric and cannot reveal how chemical modifications reshape 3D structures. To address this gap, we propose a structural database that systematically extracts and contextualizes modification sites within experimentally determined protein structures, providing a foundation for future studies of protein structure, function, and regulatory mechanisms.
resultsWe present StrucPTM, a database that extracts modified residues directly from the Protein Data Bank (PDB) structures using atom-level composition rules, substantially expanding coverage beyond annotation-dependent methods. Each validated PTM modification is mapped onto a UniProt entry. The database further characterizes residues using key structural descriptors-including secondary structure, relative solvent accessibility (RSA), and whether the PTM site lies at an interchain interface. All chains associated with the same UniProt ID are compared and grouped into homolog sets based on sequence identity. This emphasizes structural conservation among homologs, allowing PTM-induced conformational deviations to be distinguished from unrelated sequence divergence. AVAILABILITY AND IMPLEMENTATION: StrucPTM offers searchable access, interactive 3D visualization, and homolog-based structural comparison through its web interface: https://prix.hanyang.ac.kr/strucptm. The source code and datasets are permanently archived on Zenodo (DOI: 10.5281/zenodo.18939125) and are accessible via GitHub (https://github.com/HanyangBISLab/StrucPTM.git).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.